>>>Development and validation of a non-invasive prenatal diagnostic test for severe genetic syndromes

Development and validation of a non-invasive prenatal diagnostic test for severe genetic syndromes

Individual Development Project. CDTI 2014

NIMGenetics relied on the non-invasive prenatal test, developing and launching TrisoNIM®, which uses massive next-generation sequencing technology and applies the NIFTY® analysis algorithm. This CDTI-funded project made it possible to move forward in the non-invasive prenatal test development, resulting in TrisoNIM® Advance, which detects trisomies 21, 13 and 18, as well as the most frequent foetal sex and sexual aneuploidies, combined with the study of 3 microdeletion syndromes, 1p36, 2q33.1 and 5p (cri-du-chat).

2018-12-17T16:55:36+01:0017 September , 2018|